RefinedScience
Ian Shelton is a seasoned professional in venture and business development within the healthcare sector, currently serving as a Senior Venture/Business Development Fellow at CU Innovations and as a Scientific and Business Advisor for RefinedSciences. With a comprehensive background that includes roles as a Senior Venture Fellow with the CU Healthcare Innovation Fund and as a Cancer Pharmacology PhD Candidate at the University of Colorado Anschutz Medical Campus, Ian Shelton has a robust foundation in clinical research and pharmacology. Previous experience includes managing clinical trials in neuroimmunology, where Ian ensured compliance with regulatory standards, and conducting award-winning research on multiple sclerosis. Ian Shelton holds a Doctor of Philosophy in Pharmacology and a Bachelor's degree in Biology and Economics/Finance from prestigious institutions.
This person is not in any teams
RefinedScience
At RefinedScience, we seamlessly integrate top-tier clinical and biological data with expert knowledge to provide unparalleled insights. We maximize patient impact with these unique insights by optimizing clinical trial probability of success and time to actionable results. We work across biopharma and we are a trusted partner in achieving better results, faster – working together to unlock strategic advantage.